AstraZeneca’s triple-combo triumphs in two Phase III asthma trials

AstraZeneca’s triple-combo triumphs in two Phase III asthma trials

Submitted by admin on May 2, 2025 - 10:50am
Source: 
Clinical Trials Arena
News Tags: 
AstraZeneca
Breztri Aerosphere
asthma
clinical trials
Headline: 
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
snippet: 

AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) has met the primary endpoints in two Phase III asthma trials.

Do Not Allow Advertisers to Use My Personal information